Phosphorylation of Casein Kinase II by p34
IDENTIFICATION OF PHOSPHORYLATION SITES USING PHOSPHORYLATION SITE MUTANTS IN VITRO(*)
- From the Manitoba Institute of Cell Biology, Manitoba Cancer Treatment and Research Foundation and the Department of Biochemistry and Molecular Biology, University of Manitoba. 100 Olivia Street, Winnipeg, Manitoba R3E 0V9, Canada
- ¶ Research Scientist of the National Cancer Institute of Canada. To whom correspondence should be addressed. Tel.: 204-787-2177; Fax: 204-787-2190; litchfi{at}cc.umanitoba.ca.
Abstract
The α and β subunits of casein kinase II are dramatically phosphorylated in cells that are arrested in mitosis (Litchfield,
D. W., Lüscher, B., Lozeman, F. J., Eisenman, R. N., and Krebs, E. G.(1992) J. Biol. Chem. 267, 13943-13951). Comparative phosphopeptide mapping experiments indicated that the mitotic phosphorylation sites on the
α subunit of casein kinase II can be phosphorylated in vitro by p34
. In the present study, we have demonstrated that a glutathione S-transferase fusion protein encoding the C-terminal 126 amino acids of the α subunit is phosphorylated by p34
at the same sites as intact casein kinase II, indicating that the mitotic phosphorylation sites are localized within the
C-terminal domain of α. Four residues within this domain, Thr-344, Thr-360, Ser-362, and Ser-370, conform to the minimal consensus
sequence for p34
phosphorylation. Synthetic peptides corresponding to regions of α that contain each of these residues are phosphorylated
by p34
at these sites. Furthermore, alterations in the phosphorylation of the glutathione S-transferase proteins encoding the C-terminal domain of α are observed when any of the four residues are mutated to alanine.
When all four residues are mutated to alanine, the fusion protein is no longer phosphorylated by p34
at any of the sites that are phosphorylated in mitotic cells. These results indicate that Thr-344, Thr-360, Ser-362, and
Ser-370 are the sites on the α subunit of casein kinase II that are phosphorylated in mitotic cells.
Footnotes
-
↵§ Recipient of a Studentship from the George H. Sellers Endowment Fund.
-
↵* This work was supported by grants from the Manitoba Health Research Council and the National Cancer Institute of Canada with funds from the Canadian Cancer Society and from the Terry Fox Foundation (to D. W. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵1 The abbreviations used are:
- CKII
-
casein kinase II
- GST
-
glutathione S-transferase.
-
- Received June 6, 1995.
- Revision received August 8, 1995.
- © 1995 by The American Society for Biochemistry and Molecular Biology, Inc.











